EN
First therapeutic trials with Bithionol in animals affected by Fasciola hepatica are discussed in the light of literature data. The drug was used in a patient who had been infected with F. hepatica 4 years ago; one therapeutic course was followed by a complete suppression of the parasite. Within 12-month follow-up, feces and duodenal content were examined for the presence of F. hepatica eggs.